1. Home
  2. PLRX vs AIOT Comparison

PLRX vs AIOT Comparison

Compare PLRX & AIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • AIOT
  • Stock Information
  • Founded
  • PLRX 2015
  • AIOT 1993
  • Country
  • PLRX United States
  • AIOT United States
  • Employees
  • PLRX N/A
  • AIOT N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • AIOT Telecommunications Equipment
  • Sector
  • PLRX Health Care
  • AIOT Telecommunications
  • Exchange
  • PLRX Nasdaq
  • AIOT Nasdaq
  • Market Cap
  • PLRX 641.5M
  • AIOT 687.0M
  • IPO Year
  • PLRX 2020
  • AIOT N/A
  • Fundamental
  • Price
  • PLRX $12.43
  • AIOT $5.95
  • Analyst Decision
  • PLRX Strong Buy
  • AIOT Buy
  • Analyst Count
  • PLRX 7
  • AIOT 1
  • Target Price
  • PLRX $40.50
  • AIOT $10.00
  • AVG Volume (30 Days)
  • PLRX 418.7K
  • AIOT 1.2M
  • Earning Date
  • PLRX 11-07-2024
  • AIOT 11-12-2024
  • Dividend Yield
  • PLRX N/A
  • AIOT N/A
  • EPS Growth
  • PLRX N/A
  • AIOT N/A
  • EPS
  • PLRX N/A
  • AIOT N/A
  • Revenue
  • PLRX N/A
  • AIOT $221,073,000.00
  • Revenue This Year
  • PLRX N/A
  • AIOT $153.13
  • Revenue Next Year
  • PLRX $585.71
  • AIOT $21.07
  • P/E Ratio
  • PLRX N/A
  • AIOT N/A
  • Revenue Growth
  • PLRX N/A
  • AIOT 67.23
  • 52 Week Low
  • PLRX $10.22
  • AIOT $2.22
  • 52 Week High
  • PLRX $19.62
  • AIOT $6.68
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 37.61
  • AIOT 61.29
  • Support Level
  • PLRX $13.55
  • AIOT $4.80
  • Resistance Level
  • PLRX $15.85
  • AIOT $6.68
  • Average True Range (ATR)
  • PLRX 0.94
  • AIOT 0.38
  • MACD
  • PLRX -0.33
  • AIOT 0.09
  • Stochastic Oscillator
  • PLRX 15.44
  • AIOT 62.18

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About AIOT PowerFleet Inc. Common Stock

PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.

Share on Social Networks: